Literature DB >> 25745330

Cerebrospinal fluid cytokines, matrix metalloproteinases, HIV, and tuberculous meningitis.

Sim Sai Tin1, Viroj Wiwanitkit2.   

Abstract

Entities:  

Year:  2015        PMID: 25745330      PMCID: PMC4350199          DOI: 10.4103/0972-2327.144312

Source DB:  PubMed          Journal:  Ann Indian Acad Neurol        ISSN: 0972-2327            Impact factor:   1.383


× No keyword cloud information.
Sir, Raj et al. reported on “cerebrospinal fluid cytokines, matrix metalloproteinases, HIV and tuberculous meningitis.[1]” Raj et al. noted that “HIV infection did not affect a majority of the CSF cytokines and MMP levels in tuberculous meningitis (TBM) except for IL-1β level.[1]” In fact, many reports show that HIV infection results in alteration of CSFcytokine[2] and matrix metalloproteinases.[3] Juan et al. reported that “CSF INF-gamma levels (>6.4 IU/mL) are very valuable in TBM diagnosis.[4]” The question is why the observation by Raj et al. is different. First, the confounding medical disorders, including to the opportunistic infection, should be well considered. For example, the Cryptococcal meningitis can affect the CSF cytokine,[56] and cytokine therapy is also an alternative treatment for the Cryptococcal meningitis.[7] A further study with control of confounding medical disorder and treatment in HIV-infected cases is suggested.
  7 in total

1.  Increased activity of matrix metalloproteinases in the cerebrospinal fluid of patients with HIV-associated neurological diseases.

Authors:  G M Liuzzi; C M Mastroianni; M P Santacroce; M Fanelli; C D'Agostino; V Vullo; P Riccio
Journal:  J Neurovirol       Date:  2000-04       Impact factor: 2.643

2.  Adjunctive interferon-γ immunotherapy for the treatment of HIV-associated cryptococcal meningitis: a randomized controlled trial.

Authors:  Joseph N Jarvis; Graeme Meintjes; Kevin Rebe; Gertrude Ntombomzi Williams; Tihana Bicanic; Anthony Williams; Charlotte Schutz; Linda-Gail Bekker; Robin Wood; Thomas S Harrison
Journal:  AIDS       Date:  2012-06-01       Impact factor: 4.177

3.  Compartmentalization of innate immune responses in the central nervous system during cryptococcal meningitis/HIV coinfection.

Authors:  Vivek Naranbhai; Christina C Chang; Raveshni Durgiah; Saleha Omarjee; Andrew Lim; Mahomed-Yunus S Moosa; Julian H Elliot; Thumbi Ndung'u; Sharon R Lewin; Martyn A French; William H Carr
Journal:  AIDS       Date:  2014-03-13       Impact factor: 4.177

4.  Interferon gamma quantification in cerebrospinal fluid compared with PCR for the diagnosis of tuberculous meningitis.

Authors:  Rafael San Juan; Carmen Sánchez-Suárez; María J Rebollo; Dolores Folgueira; Elia Palenque; Blanca Ortuño; Carlos Lumbreras; José M Aguado
Journal:  J Neurol       Date:  2006-06-19       Impact factor: 4.849

5.  Chemokine levels and chemokine receptor expression in the blood and the cerebrospinal fluid of HIV-infected patients with cryptococcal meningitis and cryptococcosis-associated immune reconstitution inflammatory syndrome.

Authors:  Christina C Chang; Saleha Omarjee; Andrew Lim; Tim Spelman; Bernadett I Gosnell; William H Carr; Julian H Elliott; Mohamed-Yunus S Moosa; Thumbi Ndung'u; Martyn A French; Sharon R Lewin
Journal:  J Infect Dis       Date:  2013-08-01       Impact factor: 5.226

6.  Plasma cytokines, cytokine antagonists, and disease progression in African women infected with HIV-1.

Authors:  D M Thea; R Porat; K Nagimbi; M Baangi; M E St Louis; G Kaplan; C A Dinarello; G T Keusch
Journal:  Ann Intern Med       Date:  1996-04-15       Impact factor: 25.391

7.  Cerebrospinal fluid cytokines and matrix metalloproteinases in human immunodeficiency seropositive and seronegative patients of tuberculous meningitis.

Authors:  Dheeraj Rai; Ravindra Kumar Garg; Abbas Ali Mahdi; Amita Jain; Rajesh Verma; Anil Kumar Tripathi; Maneesh Kumar Singh; Hardeep Singh Malhotra; Gyan Prakash Singh; Mohammad Kaleem Ahmad
Journal:  Ann Indian Acad Neurol       Date:  2014-04       Impact factor: 1.383

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.